XVIPY logo
OTC · XVIPYMedical - DevicesUpdated Oct 30, 2026

Xvivo Perfusion AB (publ) ROE

Profitability, historical returns, and peer comparisons.

The ROE as of October 2026 (TTM) for Xvivo Perfusion AB (publ) (XVIPY) is 5.89%

According to Xvivo Perfusion AB (publ)’s latest financial reports and current stock price. The company's current ROE is 5.89%. This represents a change of 300.75% compared to the average of 1.47% of the last 4 quarters.

Xvivo Perfusion AB (publ) (XVIPY) Historical ROE (quarterly & annually)

How has XVIPY ROE performed in the past?

The mean historical ROE of Xvivo Perfusion AB (publ) over the last ten years is 1.64%. The current 5.89% ROE has changed 259.25% with respect to the historical average. Over the past ten years (40 quarters), XVIPY's ROE was at its highest in in the September 2024 quarter at 4.12%. The ROE was at its lowest in in the June 2020 quarter at -2.81%.

Quarterly (TTM)
Annual

Average

1.64%

Median

1.22%

Minimum

-4.34%

Maximum

7.98%

Xvivo Perfusion AB (publ) (XVIPY) ROE by Quarter and Year

Discovering the peaks and valleys of Xvivo Perfusion AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 266.38%

Maximum Annual ROE = 7.98%

Minimum Annual Increase = -607.11%

Minimum Annual ROE = -4.34%

Quarterly (TTM)
Annual
YearROEChange
20251.19%-85.09%
20247.98%69.11%
20234.72%266.38%
20221.29%103.17%
20210.63%-114.62%
2020-4.34%-607.11%
20190.86%-63.56%
20182.35%89.08%
20171.24%161.66%
20160.47%-82.91%

Xvivo Perfusion AB (publ) (XVIPY) Average ROE

How has XVIPY ROE performed in the past?

The current ROE of Xvivo Perfusion AB (publ) (XVIPY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.63%

5-year avg

3.16%

10-year avg

1.64%

Xvivo Perfusion AB (publ) (XVIPY) ROE vs. Peers

How is XVIPY’s ROE compared to its peers?

Xvivo Perfusion AB (publ)’s ROE is less than TransMedics Group, Inc. (32.97%),

CompanyROEMarket cap
32.97%$2.31B

Build a custom stock screener for Xvivo Perfusion AB (publ) (XVIPY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xvivo Perfusion AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xvivo Perfusion AB (publ) (XVIPY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xvivo Perfusion AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Xvivo Perfusion AB (publ)'s ROE?

How is the ROE calculated for Xvivo Perfusion AB (publ) (XVIPY)?

What is the highest ROE for Xvivo Perfusion AB (publ) (XVIPY)?

What is the 3-year average ROE for Xvivo Perfusion AB (publ) (XVIPY)?

What is the 5-year average ROE for Xvivo Perfusion AB (publ) (XVIPY)?

How does the current ROE for Xvivo Perfusion AB (publ) (XVIPY) compare to its historical average?